CPH2 is achieving a series of important milestones as we continue to advance our technology and broaden our commercial reach.
Our first 1-MW MFE220 unit has now entered the third and final stage of its factory acceptance test (FAT3), with completion expected in April 2026. Successfully completing this phase will validate the electrolyzer’s performance, supporting wider deployment and unlocking new commercial opportunities for our membrane-free electrolysis technology.
At the same time, we’ve secured several exciting collaboration agreements:
Our technology performance continues to strengthen. The scaled demonstrator unit, MFE110, has exceeded hydrogen fuel-grade purity standards and achieved medical-grade oxygen requirements—further reinforcing the reliability and scalability of our solutions.